Tecan Group company profile
Company profile
Tecan Group has 3,000 employees and is headquartered in Männedorf, Switzerland.
Headquartered in Männedorf, Switzerland, the company was founded in 1980 and builds laboratory instruments for customers in biopharmaceutical, forensic and clinical diagnostics settings. Its Life Sciences Business covers liquid handling and automation systems, microplate readers and washers, laboratory software, consumables, sequencing reagents, and immunoassays and antibodies. The Partnering Business offers contract design and manufacturing through PARAMIT, while Tecan Labwerx provides an end-to-end automation solution. Sales reach customers in Europe, North America, Asia and other international markets, and a strategic collaboration with NVIDIA Corporation aims to develop an AI-enabled platform for data-driven laboratories.
In the fiscal year ended December 2025, revenue amounted to CHF 882.5 million, down 5.5% from the prior year, while the company recorded a net loss of CHF 110.7 million. It had 3,000 employees.
Company facts
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- Switzerland
- Headquarters
- Seestrasse 103, 8708, Männedorf
- Employees
- 3,000
- Chief executive
- Monica Manotas
- Founded
- 1980
- Fiscal year
- January - December
- Listing
- TECN · SIX
- Currency
- CHF
- ISIN
- CH0012100191
- Website
- tecan.com
Tecan Group and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Tecan GroupTECN | Switzerland | $3.58B | 3,000 | 4.9% | — |
| SCHOTT Pharma1SXP | Germany | $3.74B | 5,002 | 16.4% | 25.1 |
| Fielmann GroupFIE | Germany | $3.93B | 18,213 | 13.7% | 16.4 |
| Carl Zeiss MeditecAFX | Germany | $3.07B | 5,784 | 7.2% | 23.3 |
| OttobockOBCK | Germany | $2.68B | 9,455 | 18.7% | 19.0 |
| AddLifeALIF.B | Sweden | $2.11B | 2,428 | 8.9% | 33.5 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
